Adma Biologics (ADMA) Advances But Underperforms Market: Key Facts
Portfolio Pulse from
Adma Biologics (ADMA) saw a slight increase of 0.3% in its stock price, closing at $16.92, but it underperformed compared to the broader market.

February 07, 2025 | 12:00 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Adma Biologics (ADMA) experienced a minor stock price increase of 0.3%, closing at $16.92. Despite this gain, the stock underperformed relative to the broader market.
The stock price of ADMA increased slightly by 0.3%, indicating a positive movement. However, the fact that it underperformed the broader market suggests a neutral short-term impact as the gain was not significant enough to outperform market trends.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100